» Articles » PMID: 28348479

Non-alcoholic Fatty Liver Disease Connections with Fat-free Tissues: A Focus on Bone and Skeletal Muscle

Overview
Specialty Gastroenterology
Date 2017 Mar 29
PMID 28348479
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The estimates of global incidence and prevalence of non-alcoholic fatty liver disease (NAFLD) are worrisome, due to the parallel burden of obesity and its metabolic complications. Indeed, excess adiposity and insulin resistance represent two of the major risk factors for NAFLD; interestingly, in the last years a growing body of evidence tended to support a novel mechanistic perspective, in which the liver is at the center of a complex interplay involving organs and systems, other than adipose tissue and glucose homeostasis. Bone and the skeletal muscle are fat- free tissues which appeared to be independently associated with NAFLD in several cross-sectional studies. The deterioration of bone mineral density and lean body mass, leading to osteoporosis and sarcopenia, respectively, are age-related processes. The prevalence of NAFLD also increases with age. Beyond physiological aging, the three conditions share some common underlying mechanisms, and their elucidations could be of paramount importance to design more effective treatment strategies for the management of NAFLD. In this review, we provide an overview on epidemiological data as well as on potential contributors to the connections of NAFLD with bone and skeletal muscle.

Citing Articles

The relationship between sarcopenia and metabolic dysfunction-associated fatty liver disease among the young and middle-aged populations.

Feng Z, Zhao F, Wang Z, Tang X, Xie Y, Qiu L BMC Gastroenterol. 2024; 24(1):111.

PMID: 38491346 PMC: 10943823. DOI: 10.1186/s12876-024-03192-0.


Restoring skeletal muscle mass as an independent determinant of liver fat deposition improvement in MAFLD.

Zhou T, Ye J, Luo L, Wang W, Feng S, Dong Z Skelet Muscle. 2023; 13(1):23.

PMID: 38115119 PMC: 10731792. DOI: 10.1186/s13395-023-00333-z.


Environmental Cadmium Exposure Exacerbated Bone Loss in NAFLD Mice.

Li C, Wang N, Li Y, Yang H, Li J, Zhang Z Biol Trace Elem Res. 2023; 202(10):4586-4595.

PMID: 38100013 DOI: 10.1007/s12011-023-04016-0.


Association of TNF-α, IGF-1, and IGFBP-1 levels with the severity of osteopenia in mice with nonalcoholic fatty liver disease.

Wang T, Li J, Tian Y, Zheng J, Li X, Guo S J Orthop Surg Res. 2023; 18(1):915.

PMID: 38041076 PMC: 10691127. DOI: 10.1186/s13018-023-04385-1.


The association of nonalcoholic fatty liver disease with bone mineral density in type 2 diabetes.

Du J, Ma Y, Lang H, Huang C, Zhang X Eur J Med Res. 2022; 27(1):143.

PMID: 35934712 PMC: 9358869. DOI: 10.1186/s40001-022-00775-z.


References
1.
Dawson-Hughes B, Bischoff-Ferrari H . Considerations concerning the definition of sarcopenia: response to comments. Osteoporos Int. 2016; 27(11):3147-3148. DOI: 10.1007/s00198-016-3728-y. View

2.
Ishii S, Cauley J, Crandall C, Srikanthan P, Greendale G, Huang M . Diabetes and femoral neck strength: findings from the Hip Strength Across the Menopausal Transition Study. J Clin Endocrinol Metab. 2011; 97(1):190-7. PMC: 3251942. DOI: 10.1210/jc.2011-1883. View

3.
Tahimic C, Wang Y, Bikle D . Anabolic effects of IGF-1 signaling on the skeleton. Front Endocrinol (Lausanne). 2013; 4:6. PMC: 3563099. DOI: 10.3389/fendo.2013.00006. View

4.
Cui R, Sheng H, Rui X, Cheng X, Sheng C, Wang J . Low bone mineral density in chinese adults with nonalcoholic Fatty liver disease. Int J Endocrinol. 2013; 2013:396545. PMC: 3747470. DOI: 10.1155/2013/396545. View

5.
Srikanthan P, Crandall C, Miller-Martinez D, Seeman T, Greendale G, Binkley N . Insulin resistance and bone strength: findings from the study of midlife in the United States. J Bone Miner Res. 2013; 29(4):796-803. PMC: 3935990. DOI: 10.1002/jbmr.2083. View